News
Collaborate+Connect+Commercialise 13 February 2019 – The Peter Doherty Institute Know your customer, secure your IP and build the right team were strong messages at the latest Melbourne Biomedical Precinct networking event, held in partnership with the BioMelbourne Network. The event, held at the Peter Doherty Institute, attracted an audience of around 200 people hungry to learn the secrets of successful biomedical start-ups. Key note speaker … Continue reading The rewards and challenges of biomedical start ups
MBS Leading for Organisation Impact: The Looking Glass Experience program The Melbourne Business School is offering an open programs scholarship for a woman working within a VCCC partner organisation with a focus on cancer to participate in their Leading for Organisational Impact: The Looking Glass Experience program. This scholarship opportunity is in honour of Jo Leonard who was a longstanding and valued member of the … Continue reading MBS scholarship for woman in leadership role
Funded by The Royal Melbourne Hospital Foundation, with proceeds from The Royal Melbourne Hospital Home Lottery, the new ward features a mix of single and double rooms, natural light, lifting tracks above beds and a dedicated rehabilitation gym. The new ward has capacity for 31 beds including eight high acuity beds for patients who require increased monitoring. The Royal Melbourne Hospital’s Director Neurology, Professor Mark … Continue reading The Royal Melbourne Hospital’s new state-of-the-art Acute Stroke and Neurology Ward opens its doors
Proud Precinct Partners, Polyactiva attended the recently Ophthalmology conference in Chicago, USA discussing the future of eyecare treatment and recent developments, and their early stage gamechanging projects. Eyewire TV caught up with them for a brief chat. To watch all of the discussions with eyewrite: https://eyewire.news/videos/regenxbio/ More information about Polyactiva: The company began operation in February 2010 and since its formation has secured in excess … Continue reading Polyactiva and eyewire.tv
Researchers from the Peter Doherty Institute for Infection and Immunity (Doherty Institute) and Monash University have identified immune cells, called killer T cells that can fight all influenza viruses – A, B and C – creating the potential for the development of a world-first universal, one-shot flu vaccine. The extraordinary breakthrough made by University of Melbourne PhD student, Marios Koutsakos of the Doherty Institute, was … Continue reading ‘Killer’ immune cells provide solution to elusive universal flu vaccine
More people from rural and regional Victoria with cancer will access clinical trials closer to home using the teletrial model with digital technology, thanks to a $1.5 million Andrews Labor Government funding boost. Minister for Health Jenny Mikakos today announced the launch of the Victorian Comprehensive Cancer Centre’s (VCCC) Teletrials Program in Bendigo and Albury Wodonga, which will extend to other parts of regional Victoria. … Continue reading Digital Tools Bring Cancer Trials To All Victorians
BioCurate has welcomed the Federal Government’s announcement today that the company’s partnership with MTPConnect, UniQuest, and the Medical Device Partnering Program (MDPP) will operate the $22.3 million Biomedical Translation Bridge (BTB) Program. The BTB program forms part of the Federal Government’s Medical Research Future Fund and aims to help early stage health and medical research ventures reach proof-of-concept stage. BioCurate CEO Dr Glenn Begley said … Continue reading BioCurate partnership set to bridge the biomedical translation gap
A message from Professor Shitij Kapur: As Chair of the Executive Board of the Melbourne Academic Centre for Health (MACH) Board, I am pleased to announce the appointment of internationally-renowned clinician scientist Professor Sir John Savill as the new Executive Director for the advanced health research and translation centre. John comes to the MACH from the University of Edinburgh where he serves as the Regius … Continue reading Prof Sir John Savill appointed Executive Director to the MACH
One of the hardest parts of a start-up is getting started, so we’ve brought together three of Melbourne’s brightest biomedical entrepreneurs to share their experiences, tips and advice. Here’s your opportunity to hear from these entrepreneurs who have taken the journey from great idea to business reality. Professor Mimi Tan, Dr Harris Eyre and Dr Liz Williams are all experts in their fields. They are … Continue reading The challenges and rewards of a biomedical start-up – 13 Feb
Professor Bruce Kemp, Head of SVI’s Protein Chemistry and Metabolism Unit and one of Australia’s most respected biochemists, has been honoured as an Officer of the Order of Australia. Professor Kemp was included in this year’s Australia Day Honours List for his distinguished service to biomedical research, particularly to the study of protein phosphorylation. The honour falls on the 30th anniversary of Bruce’s arrival at … Continue reading Prof Bruce Kemp receives Australia Day honour
Congratulations Professor Kathryn North, on her appointment as Companion to the Order of Australia in this year’s Australia Day awards. This honour recognises Kathryn’s national and international leadership in genomic medicine, her contribution to the advancement of genetic, neurological and child health and mentorship of young researchers. Kathryn has dedicated her life to improving genetic diagnoses, most recently in bringing together a consortium of more … Continue reading Professor Kathryn North appointed Companion to the Order of Australia.
What lies ahead for Melbourne’s biotechnology, medical technology and pharmaceutical industry in 2019? BioMelbourne Network’s annual “Hot or Not” discussion explores the global trends for the coming year with 4 speakers each presenting a short “snap shot” of what is HOT and what is NOT going into 2019 in their area of interest and expertise. Topics for discussion include: AI & IP – Raffaele Calabrese, … Continue reading Hot or Not: Trends for 2019 – 7 Feb 2019
Applications for the 2019 Melbourne Health Accelerator (MHx) cohort are now open! www.melbournehealthaccelerator.com The MHx will allow 12 start-ups to physically relocate to the Royal Melbourne Hospital. The 2019 MHx cohort will run for 13 weeks between April 8th – July 5th 2019 and will require a time commitment of 2-3 days each week from at least one founder. The MHx program involves: · A … Continue reading 2019 Melbourne Health Accelerator calls for applications
As she was considering the merits of returning to full-time work as a scientist, Stephanie Yiallourou found herself wondering about school drop-off. Although holding a meeting before 9:30am would not ruffle feathers among her male colleagues, the prospect of cradling a phone with her shoulder while getting her boys ready for the day was unappealing. And so was giving up her profession like the many female scientists … Continue reading Baker Institute introduces gender equity fellowship to support women scientists to stay in workforce
CALL FOR ABSTRACTS CLOSING SOON! The deadline for abstracts for the Lowitja Institute International Indigenous Health and Wellbeing Conference is only a week away! Make your submission to the Lowitja Institute by Friday 25 January 2019 to share your solutions-focussed research and programs with First Nations leaders, researchers, health and policy professionals, community representatives and our non-Indigenous colleagues from around the world. To find out … Continue reading Lowitja Institute call for abstracts
A new drug delays motor neurone disease progression and improves cognitive and clinical symptoms according to recently announced trial results. Research at a glance: The copper-delivery drug CuATSM improved symptoms in MND patients over six months Improvements were seen in lung function and cognition Decline in motor disability was reduced in treated patients compared to standard-of-care patients The researchers will begin a larger Phase 2 … Continue reading Motor neurone disease breakthrough: Patient trial shows impressive clinical results
TRaM are taking applications for TRaMx 2019 If you’ve been thinking about how you can have greater impact with your research, you’ve come to the right place. TRaM is now accepting applications for our first two TRaMx bootcamps of the year. Designed to grow your understanding of research translation, TRaMx will accelerate your entrepreneurial thinking and research commercialisation, using practical frameworks and methodologies. During the … Continue reading Join the next TRaMx bootcamp – 11-12 Feb 2019
Federal Health Minister Greg Hunt has today announced $25 million in funding to enhance Australia’s drug discovery capabilities at the Walter and Eliza Hall Institute’s new Drug Discovery Centre. This significant investment is helping to overcome a challenge in Australian drug discovery by enabling the translation of world-class Australian biomedical research into lifesaving medicines for patients. The funding builds upon the Institute’s own $32.1 million … Continue reading $25 million to bridge a vital gap in Australian drug discovery
Australia’s brightest MedTech entrepreneurs battled it out at last night’s National MedTech’s Got Talent National Finals in Melbourne. The top five teams secured $10,000 non-dilutive, stage-gated funding to kickstart their MedTech startup towards product-market fit and investor readiness. These teams will participate in an intensive 6-week accelerator program, with the most investible team taking out the competition, and receiving an additional $30,000. Melbourne, Australia. Friday … Continue reading Five promising MedTech companies to watch earn $10,000 pre-seed funding in the 2018 National MedTech’s Got Talent Gala Finals
The AUTM Conference, an assembly of international academic technology transfer professionals, is taking place in Austin, Texas from 10-13 February 2019. Austin has become one of the fastest growing tech hubs in the US with competitive strengths in Artificial Intelligence (AI), machine learning, and big data. Following the AUTM Conference, Austrade Americas will be hosting a strategic 2-day program for Australian researchers and technology transfer … Continue reading Artificial Intelligence (US) Mission to the US – 13-15 Feb 2019
Patients with cancer living in regional and rural Victoria will soon have access to clinical trials, on their doorstep. The first patients participating in a cancer clinical trial implemented through a new Victorian Comprehensive Cancer Centre (VCCC) Teletrials Program has begun in Albury Wodonga and Bendigo. The program provides opportunities for regional patients to participate in clinical trials without the need to travel to metropolitan centres. Dr … Continue reading Access to cancer clinical trials for all Victorians
Melbourne Biomedical Precinct Partners, CSL Limited presented new real-world data showing that its cell-based quadrivalent influenza vaccine (QIVc) was 36.2 percent more effective than standard* egg-based quadrivalent vaccines (QIVe) in preventing influenza-like illnesses during the 2017/18 influenza season in the United States. This is likely due to the predominance of the H3N2 virus and its propensity for mutation when it is adapted for influenza vaccine … Continue reading “We’re excited about it.” – CSL talks up new flu vaccine
Australian researchers have developed a tiny device that electrically stimulates the brain and could one day be used to treat conditions such as epilepsy and Parkinson’s disease without invasive surgery. They have shown for the first time that electrical stimulation can be delivered into the brain from a 4 mm diameter Stentrode™ permanently implanted inside a blood vessel. This technology opens the door for a … Continue reading Stentrode™ developed for brain treatments without major surgery
New research throws light on the predictability of seizure cycles for people with epilepsy Cycles govern most aspects of our day-to-day life and our biology. There are environmental cycles, like the 8-hour working day, 5-day working week, monthly mortgage repayments and seasonal weather patterns. Epilepsy is particularly sensitive to metabolic cycles. Picture: Shutterstock There are also cycles in our body governed by hormonal and … Continue reading Forecasting the cycle of epileptic seizures
Peter Mac was delighted to host The Hon. Greg Hunt MP, Minister for Health, to announce important changes to the PBS which will provide or improve subsidised access to life-changing cancer drugs. Minister Hunt toured Peter Mac’s labs prior to the announcement on Friday, speaking with Professor Keiran Harvey (pictured left in the above photo) about his research which is focused on Drosophilia flies. The flies have genes … Continue reading $100 million investment in new PBS listings to fight cancer
The Australian Cancer Research Foundation (ACRF) will provide $2 million to fund the creation of the ACRF Facility for Innovative Cancer Drug Discovery at the Bio21 Institute, University of Melbourne. The chief investigators, Professor Michael Parker and Dr David Ascher of Bio21, Professor Rick Pearson of the Peter MacCallum Cancer Centre and Professor John Silke of the Walter and Eliza Hall Institute, represent some of … Continue reading New ACRF cancer research facility will harness structural biology to discover innovative cancer drugs in Melbourne
Explore an unprecedented breadth of integrated, advanced cancer knowledge In 2019 the Victorian Comprehensive Cancer Centre with the University of Melbourne is offering a Master of Cancer Sciences program for the first time. The two-year, part-time course will be Australia’s first cancer-specific, wholly online program, delivered by world-class experts from the Victorian Comprehensive Cancer Centre (VCCC) and Australia’s leading university. It will equip students with … Continue reading Study Master of Cancer Science in 2019
Professor Baune has accepted an honorary appointment at the Florey Institute of Neuroscience and Mental Health and will co-head our mental health theme with Professor Andrew Lawrence Prof. Bernhard Baune (PhD, MD, MPH, FRANZCP) is Cato Chair and Head of the Department of Psychiatry at The University of Melbourne, Australia. Prof. Baune is a Fellow of the Royal Australian and New Zealand College of Psychiatrist … Continue reading Professor Bernhard Baune appointed as Co-Head of the Florey’s Mental Health Theme
Thinking about studying Biomed with the University of Melbourne in 2019? Join us on Facebook Live as we talk to a panel of Biomed students and academics about everything you need to know for 2019. This is your opportunity to chat with students and recent graduates about what it’s really like to study Biomed, careers, scholarships, internships, exchange and much, much more! Hear from … Continue reading Thinking of studying Biomedicine? – 12 Dec
Dr Georgina Such works with nanoparticles to deliver vaccines and drugs, but a breakthrough in the field could be life-changing for people with cancer We want to make a nanoparticle that works better. To find a smarter way to deliver drugs. To achieve this, we are interested in unpacking how nanoparticle properties affect the ability to deliver drugs – this means understanding how nanoparticles can … Continue reading A smarter way to deliver drugs
